Ozone therapy may be an option for COVID-19 patients
- PMID: 33829430
- DOI: 10.26355/eurrev_202103_25407
Ozone therapy may be an option for COVID-19 patients
Similar articles
-
The timeliness of ozone in the COVID era.Eur Rev Med Pharmacol Sci. 2020 May;24(9):4625-4626. doi: 10.26355/eurrev_202005_21146. Eur Rev Med Pharmacol Sci. 2020. PMID: 32432725 No abstract available.
-
Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19.Mini Rev Med Chem. 2021;21(8):1004-1016. doi: 10.2174/1389557520666201204162103. Mini Rev Med Chem. 2021. PMID: 33280595 Review.
-
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.Pediatr Hematol Oncol. 2021 May;38(4):406-409. doi: 10.1080/08880018.2020.1867267. Epub 2021 Feb 26. Pediatr Hematol Oncol. 2021. PMID: 33635161 No abstract available.
-
Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy.Pharmacol Rep. 2020 Dec;72(6):1445. doi: 10.1007/s43440-020-00191-2. Pharmacol Rep. 2020. PMID: 33206322 Free PMC article. No abstract available.
-
Update to living systematic review on drug treatments for covid-19.BMJ. 2020 Dec 17;371:m4852. doi: 10.1136/bmj.m4852. BMJ. 2020. PMID: 33334735 No abstract available.
Cited by
-
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.Int Immunopharmacol. 2021 Jul;96:107777. doi: 10.1016/j.intimp.2021.107777. Epub 2021 May 11. Int Immunopharmacol. 2021. PMID: 34020394 Free PMC article. Review.
-
Therapeutic efficacy of ozonated blood in severe COVID-19 patients: a randomized controlled trial.Front Med (Lausanne). 2025 Apr 24;12:1546767. doi: 10.3389/fmed.2025.1546767. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40342580 Free PMC article.
-
The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): a review.Med Gas Res. 2023 Oct-Dec;13(4):165-171. doi: 10.4103/2045-9912.369237. Med Gas Res. 2023. PMID: 37077113 Free PMC article. Review.
-
Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis.Int Immunopharmacol. 2022 Sep;110:109014. doi: 10.1016/j.intimp.2022.109014. Epub 2022 Jul 4. Int Immunopharmacol. 2022. PMID: 35803132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical